{"id":1670,"date":"2015-10-09T11:59:29","date_gmt":"2015-10-09T10:59:29","guid":{"rendered":"https:\/\/blogs.bmj.com\/heart-journalscan\/?p=1670"},"modified":"2015-11-12T17:08:46","modified_gmt":"2015-11-12T16:08:46","slug":"revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/","title":{"rendered":"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes"},"content":{"rendered":"<p><b><\/b><span style=\"font-weight: 400\">Among patients presenting with an acute coronary syndrome, cardiac troponin assays are the standard method for the identification of patients at high risk who benefit from early revascularization. \u00a0With advances in technology, high-sensitivity troponin (hsTn) assays are now available to identify levels of circulating troponin that were previously undetectable. \u00a0In this study, the authors sought to determine the impact of prompt revascularization on outcomes among patients with type 2 diabetes and stable ischemic heart disease. Utilizing patients from the BARI 2D study, a total of 2285 patients with stable ischemic heart disease and type 2 diabetes had hsTn measurements taken at baseline and 12 months. \u00a0Patients with an elevated hsTn were randomized to prompt revascularization or to ongoing medical therapy. \u00a0Over 5 years of follow-up from the point of revascularization, the primary composite end point was death from cardiovascular causes, myocardial infarction, or stroke. \u00a0A total of 897 (39.3%) patients were found to have a hsTn above the normal range (\u226514 ng\/l). \u00a0Compared with patients with normal hsTn levels, patients with elevated hsTn levels had a significantly increased risk for adverse events (27.1% vs 12.9% for the composite outcome; P&lt;0.001) Early revascularization in response to elevated hsTn did not improve patient outcomes in this population of patients with stable ischemic heart disease.<\/span><!--more--><\/p>\n<p><b>Conclusions<\/b><\/p>\n<p><span style=\"font-weight: 400\">Elevated hsTn in patients with stable coronary artery disease was associated with increased risk of adverse cardiovascular outcomes and death. \u00a0However, revascularization in response to the identification of elevated hsTn did not improve patient outcomes.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Summarized by Hussain Contractor and Steven M. Bradley<\/span><\/p>\n<p><span style=\"font-weight: 400\">Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med. 2015 Aug 13;373(7):610-20.<\/span><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Among patients presenting with an acute coronary syndrome, cardiac troponin assays are the standard method for the identification of patients at high risk who benefit from early revascularization. \u00a0With advances in technology, high-sensitivity troponin (hsTn) assays are now available to identify levels of circulating troponin that were previously undetectable. \u00a0In this study, the authors sought [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":192,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[279],"tags":[],"class_list":["post-1670","post","type-post","status-publish","format-standard","hentry","category-general-cardiology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes - Heart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes - Heart\" \/>\n<meta property=\"og:description\" content=\"Among patients presenting with an acute coronary syndrome, cardiac troponin assays are the standard method for the identification of patients at high risk who benefit from early revascularization. \u00a0With advances in technology, high-sensitivity troponin (hsTn) assays are now available to identify levels of circulating troponin that were previously undetectable. \u00a0In this study, the authors sought [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/\" \/>\n<meta property=\"og:site_name\" content=\"Heart\" \/>\n<meta property=\"article:published_time\" content=\"2015-10-09T10:59:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-11-12T16:08:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes\",\"datePublished\":\"2015-10-09T10:59:29+00:00\",\"dateModified\":\"2015-11-12T16:08:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/\"},\"wordCount\":298,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#organization\"},\"articleSection\":[\"General cardiology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/\",\"name\":\"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes - Heart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#website\"},\"datePublished\":\"2015-10-09T10:59:29+00:00\",\"dateModified\":\"2015-11-12T16:08:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/2015\\\/10\\\/09\\\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/\",\"name\":\"Heart\",\"description\":\"Highlighted articles from non-cardiological journals relevant to cardiology\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#organization\",\"name\":\"Heart\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/files\\\/2017\\\/11\\\/blog-logo-heart.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/files\\\/2017\\\/11\\\/blog-logo-heart.png\",\"width\":145,\"height\":34,\"caption\":\"Heart\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/heart\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes - Heart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/","og_locale":"en_US","og_type":"article","og_title":"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes - Heart","og_description":"Among patients presenting with an acute coronary syndrome, cardiac troponin assays are the standard method for the identification of patients at high risk who benefit from early revascularization. \u00a0With advances in technology, high-sensitivity troponin (hsTn) assays are now available to identify levels of circulating troponin that were previously undetectable. \u00a0In this study, the authors sought [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/","og_site_name":"Heart","article_published_time":"2015-10-09T10:59:29+00:00","article_modified_time":"2015-11-12T16:08:46+00:00","twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/"},"author":{"name":"","@id":""},"headline":"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes","datePublished":"2015-10-09T10:59:29+00:00","dateModified":"2015-11-12T16:08:46+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/"},"wordCount":298,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/heart\/#organization"},"articleSection":["General cardiology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/","url":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/","name":"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes - Heart","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/heart\/#website"},"datePublished":"2015-10-09T10:59:29+00:00","dateModified":"2015-11-12T16:08:46+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/heart\/2015\/10\/09\/revascularization-in-response-to-identification-of-elevated-high-sensitivity-troponin-in-stable-patients-does-not-improve-outcomes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/heart\/"},{"@type":"ListItem","position":2,"name":"Revascularization in response to identification of elevated high sensitivity troponin in stable patients does not improve outcomes"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/heart\/#website","url":"https:\/\/blogs.bmj.com\/heart\/","name":"Heart","description":"Highlighted articles from non-cardiological journals relevant to cardiology","publisher":{"@id":"https:\/\/blogs.bmj.com\/heart\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/heart\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/heart\/#organization","name":"Heart","url":"https:\/\/blogs.bmj.com\/heart\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/heart\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/heart\/files\/2017\/11\/blog-logo-heart.png","contentUrl":"https:\/\/blogs.bmj.com\/heart\/files\/2017\/11\/blog-logo-heart.png","width":145,"height":34,"caption":"Heart"},"image":{"@id":"https:\/\/blogs.bmj.com\/heart\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/heart\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/posts\/1670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/users\/192"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/comments?post=1670"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/posts\/1670\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/media?parent=1670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/categories?post=1670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/heart\/wp-json\/wp\/v2\/tags?post=1670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}